Clinical Trial Update: A Study of Botensilimab and Balstilimab for Rectal Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of Botensilimab and Balstilimab for microsatellite-stable rectal cancer and locally advanced rectal adenocarci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Adenocarcinoma
• Rectal Cancer

Drugs mentioned

• Balstilimab (balstilimab)
• Botensilimab (botensilimab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Microsatellite Stable Rectal Carcinoma, Locally Advanced Rectal Adenocarcinoma | Phase 2 | Status: RECRUITING